Generali Investments, Management »

Alnylam Pharmaceuticals shares owned by Generali Investments, Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Generali Investments, Management from 13F filings

Historical chart of Generali Investments, Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Generali Investments, Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Generali Investments, Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $384k 965 397.65

More positions owned by Generali Investments, Management

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Palo Alto Networks (PANW)
Crowdstrike Hldgs Cl A (CRWD)
Advanced Micro Devices (AMD)
Abbvie (ABBV)

View all positions for Generali Investments, Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals